Article

Foreword

Register or Login to View PDF Permissions
Permissions× For commercial reprint and permission enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For non-commercial reprints and permissions enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
Average (ratings)
No ratings
Your rating
Copyright Statement:

The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.

This issue of Interventional Cardiology Review includes three expert reviews of established technologies which I think many interventional cardiologists will find both interesting and useful: one on the relative merits of intravascular ultrasound and optical coherence tomography; one reviewing the value of FFR thresholds; and one on the excimer laser. Timely reviews of ‘DAPT after DES’ and of the optimal interventional management of cardiogenic shock will also be applicable to the daily practice of many interventional cardiologists. Two novel technologies are reviewed: the orbital atherectomy system offers hope of advances in the treatment of calcified coronary arteries; the Cre8 stent similarly offers hope of progress in the treatment of diabetic coronary disease. Further, the optimal general approach to diabetic coronary artery disease, and the mode of revascularisation in particular, is reviewed by Armstrong and Waldo.

The strength of the coronary section of this issue of the journal is testament to the expertise, hard work and enthusiasm of Angela Hoye, who I would like to welcome to the Editorial Board of Interventional Cardiology Review as the Coronary Section Editor. Angela has also contributed an excellent editorial (page 8).

The structural section of this issue is less extensive than usual, perhaps the calm before the storm of analysis that will inevitably follow the recent presentation and publication of the PARTNER 2a data. Balzer et al. have reviewed the EchoNavigator fusion imaging system, which aims to facilitate structural interventions including transcatheter aortic valve implantation. O’Sullivan et al. have reviewed the literature relating to the impact of mitral regurgitation on TAVI outcomes – an issue of concern in the assessment of a significant minority of potential TAVI patients. The final ‘structural’ paper is a comprehensive review of interventional therapies for resistant hypertension by Brandon and Sharif.

Finally, and of relevance to both coronary and structural interventionalists as well as to trainees and for those providing the training, Joshi and Wragg have written knowledgeably on the value of simulation training in general, and for interventional cardiologists in particular.